Format

Send to

Choose Destination
Cell. 2011 Feb 18;144(4):499-512. doi: 10.1016/j.cell.2011.01.017.

Identification of aneuploidy-selective antiproliferation compounds.

Author information

1
David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA.

Abstract

Aneuploidy, an incorrect chromosome number, is a hallmark of cancer. Compounds that cause lethality in aneuploid, but not euploid, cells could therefore provide new cancer therapies. We have identified the energy stress-inducing agent AICAR, the protein folding inhibitor 17-AAG, and the autophagy inhibitor chloroquine as exhibiting this property. AICAR induces p53-mediated apoptosis in primary mouse embryonic fibroblasts (MEFs) trisomic for chromosome 1, 13, 16, or 19. AICAR and 17-AAG, especially when combined, also show efficacy against aneuploid human cancer cell lines. Our results suggest that compounds that interfere with pathways that are essential for the survival of aneuploid cells could serve as a new treatment strategy against a broad spectrum of human tumors.

Comment in

PMID:
21315436
PMCID:
PMC3532042
DOI:
10.1016/j.cell.2011.01.017
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center